{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T03:23:02Z","timestamp":1793762582357,"version":"4.6.1"},"reference-count":78,"publisher":"American Society of Hematology","issue":"15","license":[{"start":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T00:00:00Z","timestamp":1715040000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,8,13]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Personalized cancer vaccines designed to target neoantigens represent a promising new treatment paradigm in oncology. In contrast to classical idiotype vaccines, we hypothesized that \u201cpolyvalent\u201d vaccines could be engineered for the personalized treatment of follicular lymphoma (FL) using neoantigen discovery by combined whole-exome sequencing (WES) and RNA sequencing (RNA-seq). Fifty-eight tumor samples from 57 patients with FL underwent WES and RNA-seq. Somatic and B-cell clonotype neoantigens were predicted and filtered to identify high-quality neoantigens. B-cell clonality was determined by the alignment of B-cell receptor (BCR) CDR3 regions from RNA-seq data, grouping at the protein level, and comparison with the BCR repertoire from healthy individuals using RNA-seq data. An average of 52 somatic mutations per patient (range, 2-172) were identified, and \u22652 (median, 15) high-quality neoantigens were predicted for 56 of 58 FL samples. The predicted neoantigen peptides were composed of missense mutations (77%), indels (9%), gene fusions (3%), and BCR sequences (11%). Building off of these preclinical analyses, we initiated a pilot clinical trial using personalized neoantigen vaccination combined with PD-1 blockade in patients with relapsed or refractory FL (#NCT03121677). Synthetic long peptide vaccines targeting predicted high-quality neoantigens were successfully synthesized for and administered to all 4 patients enrolled. Initial results demonstrate feasibility, safety, and potential immunologic and clinical responses. Our study suggests that a genomics-driven personalized cancer vaccine strategy is feasible for patients with FL, and this may overcome prior challenges in the field. This trial was registered at www.ClinicalTrials.gov as #NCT03121677.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/bloodadvances.2022007792","type":"journal-article","created":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T15:54:39Z","timestamp":1715097279000},"page":"4035-4049","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":19,"title":["Neoantigen landscape supports feasibility of personalized cancer vaccine for follicular lymphoma"],"prefix":"10.1182","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5598-0876","authenticated-orcid":false,"given":"Cody A.","family":"Ramirez","sequence":"first","affiliation":[{"name":"1Department of Medicine, Washington University School of Medicine, St. Louis, MO"},{"name":"2McDonnell Genome Institute, Washington University School of Medicine, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0323-7233","authenticated-orcid":false,"given":"Michelle","family":"Becker-Hapak","sequence":"additional","affiliation":[{"name":"1Department of Medicine, Washington University School of Medicine, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3855-7950","authenticated-orcid":false,"given":"Kartik","family":"Singhal","sequence":"additional","affiliation":[{"name":"1Department of Medicine, Washington University School of Medicine, St. Louis, MO"},{"name":"2McDonnell Genome Institute, Washington University School of Medicine, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1009-2247","authenticated-orcid":false,"given":"David A.","family":"Russler-Germain","sequence":"additional","affiliation":[{"name":"1Department of Medicine, Washington University School of Medicine, St. Louis, MO"},{"name":"4Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8958-7447","authenticated-orcid":false,"given":"Felix","family":"Frenkel","sequence":"additional","affiliation":[{"name":"3BostonGene Corporation, Waltham, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1631-1201","authenticated-orcid":false,"given":"Erica K.","family":"Barnell","sequence":"additional","affiliation":[{"name":"1Department of Medicine, Washington University School of Medicine, St. Louis, MO"},{"name":"2McDonnell Genome Institute, Washington University School of Medicine, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ethan D.","family":"McClain","sequence":"additional","affiliation":[{"name":"1Department of Medicine, Washington University School of Medicine, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6995-3585","authenticated-orcid":false,"given":"Sweta","family":"Desai","sequence":"additional","affiliation":[{"name":"1Department of Medicine, Washington University School of Medicine, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Schappe","sequence":"additional","affiliation":[{"name":"1Department of Medicine, Washington University School of Medicine, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5665-5706","authenticated-orcid":false,"given":"Onyinyechi C.","family":"Onyeador","sequence":"additional","affiliation":[{"name":"1Department of Medicine, Washington University School of Medicine, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3320-7764","authenticated-orcid":false,"given":"Olga","family":"Kudryashova","sequence":"additional","affiliation":[{"name":"3BostonGene Corporation, Waltham, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladislav","family":"Belousov","sequence":"additional","affiliation":[{"name":"3BostonGene Corporation, Waltham, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8680-854X","authenticated-orcid":false,"given":"Alexander","family":"Bagaev","sequence":"additional","affiliation":[{"name":"3BostonGene Corporation, Waltham, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Ocheredko","sequence":"additional","affiliation":[{"name":"3BostonGene Corporation, Waltham, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4378-7328","authenticated-orcid":false,"given":"Susanna","family":"Kiwala","sequence":"additional","affiliation":[{"name":"2McDonnell Genome Institute, Washington University School of Medicine, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasreet","family":"Hundal","sequence":"additional","affiliation":[{"name":"2McDonnell Genome Institute, Washington University School of Medicine, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary L.","family":"Skidmore","sequence":"additional","affiliation":[{"name":"1Department of Medicine, Washington University School of Medicine, St. Louis, MO"},{"name":"2McDonnell Genome Institute, Washington University School of Medicine, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1224-3478","authenticated-orcid":false,"given":"Marcus P.","family":"Watkins","sequence":"additional","affiliation":[{"name":"1Department of Medicine, Washington University School of Medicine, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0577-4705","authenticated-orcid":false,"given":"Thomas B.","family":"Mooney","sequence":"additional","affiliation":[{"name":"2McDonnell Genome Institute, Washington University School of Medicine, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7547-5789","authenticated-orcid":false,"given":"Jason R.","family":"Walker","sequence":"additional","affiliation":[{"name":"2McDonnell Genome Institute, Washington University School of Medicine, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6299-9230","authenticated-orcid":false,"given":"Kilannin","family":"Krysiak","sequence":"additional","affiliation":[{"name":"1Department of Medicine, Washington University School of Medicine, St. Louis, MO"},{"name":"2McDonnell Genome Institute, Washington University School of Medicine, St. Louis, MO"},{"name":"5Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4884-7510","authenticated-orcid":false,"given":"Felicia","family":"Gomez","sequence":"additional","affiliation":[{"name":"1Department of Medicine, Washington University School of Medicine, St. Louis, MO"},{"name":"2McDonnell Genome Institute, Washington University School of Medicine, St. Louis, MO"},{"name":"5Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2766-9551","authenticated-orcid":false,"given":"Catrina C.","family":"Fronick","sequence":"additional","affiliation":[{"name":"2McDonnell Genome Institute, Washington University School of Medicine, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert S.","family":"Fulton","sequence":"additional","affiliation":[{"name":"2McDonnell Genome Institute, Washington University School of Medicine, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert D.","family":"Schreiber","sequence":"additional","affiliation":[{"name":"4Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO"},{"name":"5Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5744-0670","authenticated-orcid":false,"given":"Neha","family":"Mehta-Shah","sequence":"additional","affiliation":[{"name":"1Department of Medicine, Washington University School of Medicine, St. Louis, MO"},{"name":"4Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda F.","family":"Cashen","sequence":"additional","affiliation":[{"name":"1Department of Medicine, Washington University School of Medicine, St. Louis, MO"},{"name":"4Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0459-6609","authenticated-orcid":false,"given":"Brad S.","family":"Kahl","sequence":"additional","affiliation":[{"name":"1Department of Medicine, Washington University School of Medicine, St. Louis, MO"},{"name":"4Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4767-6409","authenticated-orcid":false,"given":"Ravshan","family":"Ataullakhanov","sequence":"additional","affiliation":[{"name":"3BostonGene Corporation, Waltham, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8470-394X","authenticated-orcid":false,"given":"Nancy L.","family":"Bartlett","sequence":"additional","affiliation":[{"name":"1Department of Medicine, Washington University School of Medicine, St. Louis, MO"},{"name":"4Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6388-446X","authenticated-orcid":false,"given":"Malachi","family":"Griffith","sequence":"additional","affiliation":[{"name":"1Department of Medicine, Washington University School of Medicine, St. Louis, MO"},{"name":"2McDonnell Genome Institute, Washington University School of Medicine, St. Louis, MO"},{"name":"4Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO"},{"name":"6Department of Genetics, Washington University School of Medicine, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0843-4271","authenticated-orcid":false,"given":"Obi L.","family":"Griffith","sequence":"additional","affiliation":[{"name":"1Department of Medicine, Washington University School of Medicine, St. Louis, MO"},{"name":"2McDonnell Genome Institute, Washington University School of Medicine, St. Louis, MO"},{"name":"4Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO"},{"name":"6Department of Genetics, Washington University School of Medicine, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8705-2887","authenticated-orcid":false,"given":"Todd A.","family":"Fehniger","sequence":"additional","affiliation":[{"name":"1Department of Medicine, Washington University School of Medicine, St. Louis, MO"},{"name":"4Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2024,7,29]]},"reference":[{"issue":"48","key":"2024082015454673800_bib1","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/jncimonographs\/lgu006","article-title":"Medical history, lifestyle, family history, and occupational risk factors for follicular lymphoma: the InterLymph Non-Hodgkin Lymphoma Subtypes Project","volume":"2014","author":"Linet","year":"2014","journal-title":"J\u00a0Natl Cancer Inst Monogr"},{"issue":"11","key":"2024082015454673800_bib2","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1182\/blood.V89.11.3909","article-title":"A\u00a0clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin\u2019s lymphoma","volume":"89","author":"The Non-Hodgkin's Lymphoma Classification Project","year":"1997","journal-title":"Blood"},{"issue":"17","key":"2024082015454673800_bib3","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1182\/blood-2015-11-624288","article-title":"Follicular lymphoma: evolving therapeutic strategies","volume":"127","author":"Kahl","year":"2016","journal-title":"Blood"},{"issue":"9383","key":"2024082015454673800_bib4","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S0140-6736(03)14110-4","article-title":"Long-term effect of a watch and wait policy versus immediate systemic treatment for asymptomatic advanced-stage non-Hodgkin lymphoma: a randomised controlled trial","volume":"362","author":"Ardeshna","year":"2003","journal-title":"Lancet"},{"issue":"9","key":"2024082015454673800_bib5","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1093\/jnci\/djk152","article-title":"Immunochemotherapy with rituximab and overall survival in patients with indolent or mantle cell lymphoma: a systematic review and meta-analysis","volume":"99","author":"Schulz","year":"2007","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"12","key":"2024082015454673800_bib6","doi-asserted-by":"crossref","first-page":"3725","DOI":"10.1182\/blood-2005-01-0016","article-title":"Frontline therapy with rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) significantly improves the outcome for patients with advanced-stage follicular lymphoma compared with therapy with CHOP alone: results of a prospective randomized study of the German Low-Grade Lymphoma Study Group","volume":"106","author":"Hiddemann","year":"2005","journal-title":"Blood"},{"issue":"10","key":"2024082015454673800_bib7","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1200\/JCO.1997.15.10.3266","article-title":"IDEC-C2B8: results of a phase I multiple-dose trial in patients with relapsed non-Hodgkin\u2019s lymphoma","volume":"15","author":"Maloney","year":"1997","journal-title":"J\u00a0Clin Oncol"},{"issue":"12","key":"2024082015454673800_bib8","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1200\/JCO.18.00605","article-title":"First-line treatment of patients with indolent non-Hodgkin lymphoma or mantle-cell lymphoma with bendamustine plus rituximab versus R-CHOP or R-CVP: results of the BRIGHT 5-Year Follow-Up Study","volume":"37","author":"Flinn","year":"2019","journal-title":"J\u00a0Clin Oncol"},{"issue":"suppl 1","key":"2024082015454673800_bib9","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/hon.2853","article-title":"High-risk follicular lymphoma: treatment options","volume":"39","author":"Kahl","year":"2021","journal-title":"Hematol Oncol"},{"issue":"1","key":"2024082015454673800_bib10","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S1470-2045(21)00591-X","article-title":"Axicabtagene ciloleucel in relapsed or refractory indolent non-Hodgkin lymphoma (ZUMA-5): a single-arm, multicentre, phase 2 trial","volume":"23","author":"Jacobson","year":"2022","journal-title":"Lancet Oncol"},{"issue":"6230","key":"2024082015454673800_bib11","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1126\/science.aaa4971","article-title":"Neoantigens in cancer immunotherapy","volume":"348","author":"Schumacher","year":"2015","journal-title":"Science"},{"issue":"4","key":"2024082015454673800_bib12","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/nrc.2016.154","article-title":"Targeting neoantigens to augment antitumour immunity","volume":"17","author":"Yarchoan","year":"2017","journal-title":"Nat Rev"},{"key":"2024082015454673800_bib13","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1146\/annurev-immunol-042617-053402","article-title":"Cancer neoantigens","volume":"37","author":"Schumacher","year":"2019","journal-title":"Annu Rev Immunol"},{"issue":"15","key":"2024082015454673800_bib14","doi-asserted-by":"crossref","first-page":"4238","DOI":"10.7150\/thno.24387","article-title":"Personalized cancer neoantigen vaccines come of age","volume":"8","author":"Chu","year":"2018","journal-title":"Theranostics"},{"issue":"6","key":"2024082015454673800_bib15","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/nm.3161","article-title":"Mining exomic sequencing data to identify mutated antigens recognized by adoptively transferred tumor-reactive T cells","volume":"19","author":"Robbins","year":"2013","journal-title":"Nat Med"},{"issue":"7662","key":"2024082015454673800_bib16","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nature22991","article-title":"An immunogenic personal neoantigen vaccine for patients with melanoma","volume":"547","author":"Ott","year":"2017","journal-title":"Nature"},{"issue":"7738","key":"2024082015454673800_bib17","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/s41586-018-0792-9","article-title":"Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial","volume":"565","author":"Keskin","year":"2019","journal-title":"Nature"},{"issue":"6266","key":"2024082015454673800_bib18","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1126\/science.aad1253","article-title":"Immunogenicity of somatic mutations in human gastrointestinal cancers","volume":"350","author":"Tran","year":"2015","journal-title":"Science"},{"issue":"10","key":"2024082015454673800_bib19","doi-asserted-by":"crossref","first-page":"3981","DOI":"10.1172\/JCI82416","article-title":"Isolation of neoantigen-specific T cells from tumor and peripheral lymphocytes","volume":"125","author":"Cohen","year":"2015","journal-title":"J\u00a0Clin Invest"},{"issue":"4","key":"2024082015454673800_bib20","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/nm.4051","article-title":"Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patients","volume":"22","author":"Gros","year":"2016","journal-title":"Nat Med"},{"issue":"6184","key":"2024082015454673800_bib21","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1126\/science.1251102","article-title":"Cancer immunotherapy based on mutation-specific CD4+ T cells in a patient with epithelial cancer","volume":"344","author":"Tran","year":"2014","journal-title":"Science"},{"issue":"1","key":"2024082015454673800_bib22","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nm.3773","article-title":"High-throughput epitope discovery reveals frequent recognition of neo-antigens by CD4+ T cells in human melanoma","volume":"21","author":"Linnemann","year":"2015","journal-title":"Nat Med"},{"issue":"6291","key":"2024082015454673800_bib23","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1126\/science.aaf2288","article-title":"Targeting of cancer neoantigens with donor-derived T cell receptor repertoires","volume":"352","author":"Str\u00f8nen","year":"2016","journal-title":"Science"},{"issue":"5","key":"2024082015454673800_bib24","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1158\/1078-0432.CCR-13-2147","article-title":"Surveillance of the tumor mutanome by T cells during progression from primary to recurrent ovarian cancer","volume":"20","author":"Wick","year":"2014","journal-title":"Clin Cancer Res"},{"issue":"9","key":"2024082015454673800_bib25","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1158\/2326-6066.CIR-15-0088","article-title":"Exome sequencing to predict neoantigens in melanoma","volume":"3","author":"Pritchard","year":"2015","journal-title":"Cancer Immunol Res"},{"issue":"11","key":"2024082015454673800_bib26","doi-asserted-by":"crossref","first-page":"e1213931","DOI":"10.1080\/2162402X.2016.1213931","article-title":"Identification of immunotherapeutic targets by genomic profiling of rectal NET metastases","volume":"5","author":"Ko\u015falo\u011flu","year":"2016","journal-title":"OncoImmunology"},{"issue":"3","key":"2024082015454673800_bib27","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1158\/2159-8290.CD-16-0828","article-title":"Evolution of neoantigen landscape during immune checkpoint blockade in non-small cell lung cancer","volume":"7","author":"Anagnostou","year":"2017","journal-title":"Cancer Discov"},{"issue":"6230","key":"2024082015454673800_bib28","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1126\/science.aaa1348","article-title":"Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non\u2013small cell lung cancer","volume":"348","author":"Rizvi","year":"2015","journal-title":"Science"},{"issue":"2","key":"2024082015454673800_bib29","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.immuni.2017.02.001","article-title":"Loss of PTEN is associated with resistance to anti-PD-1 checkpoint blockade therapy in metastatic uterine leiomyosarcoma","volume":"46","author":"George","year":"2017","journal-title":"Immunity"},{"issue":"6349","key":"2024082015454673800_bib30","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1126\/science.aan6733","article-title":"Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade","volume":"357","author":"Le","year":"2017","journal-title":"Science"},{"issue":"3","key":"2024082015454673800_bib31","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1136\/gutjnl-2015-309453","article-title":"T\u00a0cell neoepitope discovery in colorectal cancer by high throughput profiling of somatic mutations in expressed genes","volume":"66","author":"Mennonna","year":"2017","journal-title":"Gut"},{"issue":"9","key":"2024082015454673800_bib32","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1158\/1078-0432.CCR-15-2023","article-title":"Toward personalized lymphoma immunotherapy: identification of common driver mutations recognized by patient CD8+ T cells","volume":"22","author":"Nielsen","year":"2016","journal-title":"Clin Cancer Res"},{"issue":"20","key":"2024082015454673800_bib33","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1200\/JCO.2010.33.3005","article-title":"Vaccination with patient-specific tumor-derived antigen in first remission improves disease-free survival in follicular lymphoma","volume":"29","author":"Schuster","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"issue":"17","key":"2024082015454673800_bib34","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1200\/JCO.2012.43.9273","article-title":"Active idiotypic vaccination versus control immunotherapy for follicular lymphoma","volume":"32","author":"Levy","year":"2014","journal-title":"J\u00a0Clin Oncol"},{"issue":"18","key":"2024082015454673800_bib35","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.1200\/JCO.2008.19.8903","article-title":"Placebo-controlled phase III trial of patient-specific immunotherapy with mitumprotimut-T and granulocyte-macrophage colony-stimulating factor after rituximab in patients with follicular lymphoma","volume":"27","author":"Freedman","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"issue":"3","key":"2024082015454673800_bib36","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.cell.2020.09.015","article-title":"Key parameters of tumor epitope immunogenicity revealed through a consortium approach improve neoantigen prediction","volume":"183","author":"Wells","year":"2020","journal-title":"Cell"},{"issue":"1","key":"2024082015454673800_bib37","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s13073-019-0666-2","article-title":"Best practices for bioinformatic characterization of neoantigens for clinical utility","volume":"11","author":"Richters","year":"2019","journal-title":"Genome Med"},{"issue":"7457","key":"2024082015454673800_bib38","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nature12213","article-title":"Mutational heterogeneity in cancer and the search for new cancer-associated genes","volume":"499","author":"Lawrence","year":"2013","journal-title":"Nature"},{"issue":"7463","key":"2024082015454673800_bib39","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nature12477","article-title":"Signatures of mutational processes in human cancer","volume":"500","author":"Alexandrov","year":"2013","journal-title":"Nature"},{"issue":"4","key":"2024082015454673800_bib40","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1182\/blood-2016-07-729954","article-title":"Recurrent somatic mutations affecting B-cell receptor signaling pathway genes in follicular lymphoma","volume":"129","author":"Krysiak","year":"2017","journal-title":"Blood"},{"issue":"4","key":"2024082015454673800_bib41","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nrc1589","article-title":"Mechanisms of B-cell lymphoma pathogenesis","volume":"5","author":"K\u00fcppers","year":"2005","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"2024082015454673800_bib42","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/ng.2653","article-title":"The Genotype-Tissue Expression (GTEx) project","volume":"45","author":"Lonsdale","year":"2013","journal-title":"Nat Genet"},{"issue":"1","key":"2024082015454673800_bib43","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13075-017-1220-5","article-title":"Discovery of new candidate genes for rheumatoid arthritis through integration of genetic association data with expression pathway analysis","volume":"19","author":"Shchetynsky","year":"2017","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"2024082015454673800_bib44","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s13073-018-0558-x","article-title":"Disease-specific regulation of gene expression in a comparative analysis of juvenile idiopathic arthritis and inflammatory bowel disease","volume":"10","author":"Mo","year":"2018","journal-title":"Genome Med"},{"issue":"1","key":"2024082015454673800_bib45","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13073-015-0168-9","article-title":"Widespread intron retention diversifies most cancer transcriptomes","volume":"7","author":"Dvinge","year":"2015","journal-title":"Genome Med"},{"issue":"12","key":"2024082015454673800_bib46","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1038\/s41591-018-0237-x","article-title":"Longitudinal personal DNA methylome dynamics in a human with a chronic condition","volume":"24","author":"Chen","year":"2018","journal-title":"Nat Med"},{"key":"2024082015454673800_bib47","doi-asserted-by":"crossref","first-page":"6042","DOI":"10.1038\/ncomms7042","article-title":"Aberrant splicing of U12-type introns is the hallmark of ZRSR2 mutant myelodysplastic syndrome","volume":"6","author":"Madan","year":"2015","journal-title":"Nat Commun"},{"issue":"47","key":"2024082015454673800_bib48","doi-asserted-by":"crossref","first-page":"16802","DOI":"10.1073\/pnas.1413374111","article-title":"Sample processing obscures cancer-specific alterations in leukemic transcriptomes","volume":"111","author":"Dvinge","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"16","key":"2024082015454673800_bib49","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1182\/blood-2012-05-430876","article-title":"SF3B1 haploinsufficiency leads to formation of ring sideroblasts in myelodysplastic syndromes","volume":"120","author":"Visconte","year":"2012","journal-title":"Blood"},{"issue":"7","key":"2024082015454673800_bib50","doi-asserted-by":"crossref","first-page":"e102977","DOI":"10.1371\/journal.pone.0102977","article-title":"Integrative genomic and transcriptomic analysis identified candidate genes implicated in the pathogenesis of hepatosplenic T-cell lymphoma","volume":"9","author":"Finalet Ferreiro","year":"2014","journal-title":"PLoS One"},{"issue":"5","key":"2024082015454673800_bib51","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/nmeth.3364","article-title":"MiXCR: software for comprehensive adaptive immunity profiling","volume":"12","author":"Bolotin","year":"2015","journal-title":"Nat Methods"},{"issue":"6","key":"2024082015454673800_bib52","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/s41592-021-01142-2","article-title":"TRUST4: immune repertoire reconstruction from bulk and single-cell RNA-seq data","volume":"18","author":"Song","year":"2021","journal-title":"Nat Methods"},{"issue":"3","key":"2024082015454673800_bib53","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1158\/2326-6066.CIR-19-0401","article-title":"pVACtools: a computational toolkit to identify and visualize cancer neoantigens","volume":"8","author":"Hundal","year":"2020","journal-title":"Cancer Immunol Res"},{"issue":"10","key":"2024082015454673800_bib54","doi-asserted-by":"crossref","first-page":"E1116","DOI":"10.1073\/pnas.1501199112","article-title":"Mutations in early follicular lymphoma progenitors are associated with suppressed antigen presentation","volume":"112","author":"Green","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"2024082015454673800_bib55","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/s41591-020-01206-4","article-title":"Personal neoantigen vaccines induce persistent memory T cell responses and epitope spreading in patients with melanoma","volume":"27","author":"Hu","year":"2021","journal-title":"Nat Med"},{"issue":"6236","key":"2024082015454673800_bib56","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1126\/science.aaa3828","article-title":"Cancer immunotherapy. A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells","volume":"348","author":"Carreno","year":"2015","journal-title":"Science"},{"issue":"7662","key":"2024082015454673800_bib57","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nature23003","article-title":"Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer","volume":"547","author":"Sahin","year":"2017","journal-title":"Nature"},{"issue":"2","key":"2024082015454673800_bib58","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.immuni.2017.08.001","article-title":"Making it personal: neoantigen vaccines in metastatic melanoma","volume":"47","author":"Hellmann","year":"2017","journal-title":"Immunity"},{"issue":"1","key":"2024082015454673800_bib59","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.celrep.2013.12.027","article-title":"Genetics of follicular lymphoma transformation","volume":"6","author":"Pasqualucci","year":"2014","journal-title":"Cell Rep"},{"issue":"9","key":"2024082015454673800_bib60","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1182\/blood-2012-09-457283","article-title":"Hierarchy in somatic mutations arising during genomic evolution and progression of follicular lymphoma","volume":"121","author":"Green","year":"2013","journal-title":"Blood"},{"issue":"2","key":"2024082015454673800_bib61","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/ng.2856","article-title":"Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma","volume":"46","author":"Okosun","year":"2014","journal-title":"Nat Genet"},{"issue":"4","key":"2024082015454673800_bib62","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1182\/blood-2014-04-571786","article-title":"BCL2 mutations are associated with increased risk of transformation and shortened survival in follicular lymphoma","volume":"125","author":"Correia","year":"2015","journal-title":"Blood"},{"issue":"18","key":"2024082015454673800_bib63","doi-asserted-by":"crossref","first-page":"5524","DOI":"10.1182\/bloodadvances.2023010779","article-title":"Mutations associated with progression in follicular lymphoma predict inferior outcomes at diagnosis: Alliance A151303","volume":"7","author":"Russler-Germain","year":"2023","journal-title":"Blood Adv"},{"issue":"10","key":"2024082015454673800_bib64","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1038\/nm.3943","article-title":"The histone lysine methyltransferase KMT2D sustains a gene expression program that represses B cell lymphoma development","volume":"21","author":"Ortega-Molina","year":"2015","journal-title":"Nat Med"},{"issue":"10","key":"2024082015454673800_bib65","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1038\/nm.3940","article-title":"Disruption of KMT2D perturbs germinal center B cell development and promotes lymphomagenesis","volume":"21","author":"Zhang","year":"2015","journal-title":"Nat Med"},{"issue":"31","key":"2024082015454673800_bib66","doi-asserted-by":"crossref","first-page":"50594","DOI":"10.18632\/oncotarget.16385","article-title":"Identification of KANSARL as the first cancer predisposition fusion gene specific to the population of European ancestry origin","volume":"8","author":"Zhou","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"2024082015454673800_bib67","doi-asserted-by":"crossref","first-page":"5179","DOI":"10.1038\/s41598-019-41675-3","article-title":"Detection of novel fusion-transcripts by RNA-seq in T-cell lymphoblastic lymphoma","volume":"9","author":"L\u00f3pez-Nieva","year":"2019","journal-title":"Sci Rep"},{"issue":"1","key":"2024082015454673800_bib68","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1038\/s41598-020-58165-6","article-title":"Fusion transcripts in normal human cortex increase with age and show distinct genomic features for single cells and tissues","volume":"10","author":"Mehani","year":"2020","journal-title":"Sci Rep"},{"issue":"8","key":"2024082015454673800_bib69","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/ng.2334","article-title":"Structural haplotypes and recent evolution of the human 17q21.31 region","volume":"44","author":"Boettger","year":"2012","journal-title":"Nat Genet"},{"issue":"10","key":"2024082015454673800_bib70","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1113205","article-title":"Intratumor heterogeneity and branched evolution revealed by multiregion sequencing","volume":"366","author":"Gerlinger","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"6206","key":"2024082015454673800_bib71","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1126\/science.1253462","article-title":"Spatial and temporal diversity in genomic instability processes defines lung cancer evolution","volume":"346","author":"de Bruin","year":"2014","journal-title":"Science"},{"issue":"6280","key":"2024082015454673800_bib72","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1126\/science.aaf1490","article-title":"Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade","volume":"351","author":"McGranahan","year":"2016","journal-title":"Science"},{"issue":"29","key":"2024082015454673800_bib73","doi-asserted-by":"crossref","first-page":"eaat1435","DOI":"10.1126\/sciimmunol.aat1435","article-title":"The immune system profoundly restricts intratumor genetic heterogeneity","volume":"3","author":"Milo","year":"2018","journal-title":"Sci Immunol"},{"key":"2024082015454673800_bib74","doi-asserted-by":"crossref","first-page":"e41090","DOI":"10.7554\/eLife.41090","article-title":"Rejection of immunogenic tumor clones is limited by clonal fraction","volume":"7","author":"Gejman","year":"2018","journal-title":"Elife"},{"issue":"47","key":"2024082015454673800_bib75","doi-asserted-by":"crossref","first-page":"23662","DOI":"10.1073\/pnas.1906026116","article-title":"Immunological ignorance is an enabling feature of the oligo-clonal T cell response to melanoma neoantigens","volume":"116","author":"Linette","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"2024082015454673800_bib76","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1158\/2159-8290.CD-21-0291","article-title":"Characterization of the genomic and immunological diversity of malignant brain tumors through multi-sector analysis","volume":"12","author":"Schaettler","year":"2021","journal-title":"Cancer Discov"},{"issue":"10","key":"2024082015454673800_bib77","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.molmed.2017.08.007","article-title":"Neoantigen vaccines pass the immunogenicity test","volume":"23","author":"Linette","year":"2017","journal-title":"Trends Mol Med"},{"issue":"1","key":"2024082015454673800_bib78","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1001\/jamaoncol.2018.4051","article-title":"Combining immune checkpoint blockade and tumor-specific vaccine for patients with incurable human papillomavirus 16-related cancer: a phase 2 clinical trial","volume":"5","author":"Massarelli","year":"2019","journal-title":"JAMA Oncol"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/8\/15\/4035\/2238957\/blooda_adv-2022-007792-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/8\/15\/4035\/2238957\/blooda_adv-2022-007792-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,20]],"date-time":"2024-08-20T11:46:32Z","timestamp":1724154392000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/8\/15\/4035\/516029\/Neoantigen-landscape-supports-feasibility-of"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,29]]},"references-count":78,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2024,8,13]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2022007792","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2022.01.06.22268805","asserted-by":"object"}]},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,29]]}}}